Cite
HARVARD Citation
Bertini, E. et al. (n.d.). Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet neurology. 16 (7), pp. 513-522. [Online].